Boea Wisdom
柏意慧心
Boea Wisdom (柏意慧心) is a Hangzhou-based medical-device company whose DetecMicro® vascular-intervention surgical-planning software won China's first NMPA Class III approval in that category in November 2023 . Linear Capital, which lists the firm in its portfolio, groups it alongside other hard-tech bets such as Lingyang Technologies and Bitsrealm . The elsewhere corpus does not cover the company's founding date, team background, or funding history beyond this approval milestone.
AI-generated — may contain errors, please verify.
Coverage
After the Start of Summer, Growing Without Reserve | Linear Quarterly
Abundant sunshine, lush growth.
Before the Start of Winter, Building Inner Strength | Linear Quarterly
Fearless through the winter, growing inward.
The First Newsletter of Autumn | Linear Quarterly
Cycles turn, and Wanwu Capital begins to harvest.
Linear Capital | Linear Path, Nonlinear Growth
Striving to become China's best frontier technology and innovation fund.
Linear Capital Portfolio Company | Boyi Huixin Secures China's First NMPA Class III Approval for Vascular Interventional Surgery Planning Software!
On November 1, 2023, DetecMicro®, a vascular interventional surgical planning software independently developed by Boyi Huixin (Hangzhou) Network Technology Co., Ltd. ("Boyi Huixin"), a portfolio company of Linear Capital, officially received Class III medical device registration approval (National Medical Device Registration Certificate No. 20233211596) from the National Medical Products Administration (NMPA). DetecMicro
Linear Capital portfolio company **Baiyi Huixin** launches **DetecMicro**, a vascular interventional surgery planning software
On June 16, 2023, **Baiyi Huixin held its product launch event in Beijing under the theme "Seeing the Small to Know the Great, Moving to See the Future." At the event, the company unveiled its DetecMicro vascular interventional surgical planning software.**
